Australia's Cyclopharm rises on HY revenue forecast
02/07/2026 03:53
BUZZ-Australia's Cyclopharm rises on HY revenue forecast ** Shares of Australia's Cyclopharm CYC.AX gain as much as 6% to A$0.530, their highest since June 24
** Radiopharmaceutical firm says it expects HY global revenue of A$17.1 million ($11.80 million), up 11% from prior corresponding period
** Says delays in finalisation process have resulted in deferral of Cyclopharm's guidance of 250–300 revenue-generating U.S. locations to after December 31
** CYC down 47.5% YTD
($1 = 1.4497 Australian dollars)
(Reporting by Keshav Singh Chundawat in Bengaluru)
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair